Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07054944 · ClinicalTrials.gov registry record
Tumor-Lymph Node Mapping
A clinical trial, sponsored by University of Rochester.
- Recruiting
- Registry status
- 10
- Enrollment target
NCT07054944 is a clinical trial that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 10 participants.
The verdict
NCT07054944 is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the feasibility and safety of ICG-guided intraoperative lymphography for detecting sentinel lymph nodes (SLN) in pediatric patients with solid tumors who require retroperitoneal lymph node dissection/sampling. This trial is a single-site cross-sectional study. The injection of ICG directly into lymphatics draining the primary tumor will take place at the time of operation after the patient is under anesthesia.
Interventions
- DIAGNOSTIC_TEST ICG (Indocyanine Green)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-04-13 |
| Est. Completion | 2028-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07054944
The ClinicalTrials.gov registry entry for NCT07054944 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ICG (Indocyanine Green) is the first listed.
NCT07054944 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07054944 about?
NCT07054944 is a clinical study titled "Tumor-Lymph Node Mapping". The purpose of this study is to assess the feasibility and safety of ICG-guided intraoperative lymphography for detecting sentinel lymph nodes (SLN) in pediatric patients with solid tumors who require retroperitoneal lymph node dissection/sampling. This trial is a single-site cross-sectional study....
What is the current status of trial NCT07054944?
This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2026-04-13. Estimated completion is 2028-07-30.
What interventions are being tested in trial NCT07054944?
The interventions under investigation include: ICG (Indocyanine Green) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07054944?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.